podcast.de
Anmeldung
Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 15/22 Podcast
  4. IFN-gamma impairs release of IL-8 by IL-1 beta-stimulated A549 lung carcinoma cells
Background: Production of interferon (IFN)-gamma is key to
efficient anti-tumor immunity. The present study was set out to
investigate effects of IFN. on the release of the potent
pro-angiogenic mediator IL-8 by human A549 lung carcinoma cells.
Methods: A549 cells were cultured and stimulated with interleukin
(IL)-1 beta alone or in combination with IFN gamma. IL-8 production
by these cells was analyzed with enzyme linked immuno sorbent assay
(ELISA). mRNA-expression was analyzed by real-time PCR and RNase
protection assay (RPA), respectively. Expression of inhibitor-kappa
B alpha, cellular IL-8, and cyclooxygenase-2 was analyzed by
Western blot analysis. Results: Here we demonstrate that IFN gamma
efficiently reduced IL-8 secretion under the influence of IL-1
beta. Surprisingly, real-time PCR analysis and RPA revealed that
the inhibitory effect of IFN gamma on IL-8 was not associated with
significant changes in mRNA levels. These observations concurred
with lack of a modulatory activity of IFN gamma on IL-1
beta-induced NF-kappa B activation as assessed by cellular I kappa
B levels. Moreover, analysis of intracellular IL-8 suggests that
IFN gamma modulated IL-8 secretion by action on the
posttranslational level. In contrast to IL-8, IL-1 beta-induced
cyclooxygenase-2 expression and release of IL-6 were not affected
by IFN gamma indicating that modulation of IL-1 beta action by this
cytokine displays specificity. Conclusion: Data presented herein
agree with an angiostatic role of IFN gamma as seen in rodent
models of solid tumors and suggest that increasing T helper type I
(Th1)-like functions in lung cancer patients e.g. by local delivery
of IFN gamma may mediate therapeutic benefit via mechanisms that
potentially include modulation of pro-angiogenic IL-8.

Weitere Episoden

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

vor 17 Jahren
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

vor 17 Jahren
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

vor 17 Jahren
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

vor 17 Jahren
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

vor 17 Jahren
Alle Episoden anzeigen
In Podcasts werben
Schalte jetzt Werbung in Podcasts.
Episode melden

„IFN-gamma impairs release of IL-8 by IL-1 beta-stimulated A549 lung carcinoma cells“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz